AGL-2263 is a novel insulin receptor inhibitor.
For research use only. We do not sell to patients.
Name | AGL-2263 |
---|---|
Iupac Chemical Name | (E)-2-(3,4-Dihydroxybenzoyl)-3-(2-oxo-3H-1,3-benzoxazol-5-yl)prop-2-enenitrile |
Synonyms | AGL-2263 |
Molecular Formula | C17H10N2O5 |
Molecular Weight | 322.276 |
Smile | N#C/C(C(C1=CC=C(O)C(O)=C1)=O)=C\C2=CC=C(OC(N3)=O)C3=C2 |
InChiKey | IUGRBTCJEYEDIY-VZUCSPMQSA-N |
InChi | InChI=1S/C17H10N2O5/c18-8-11(16(22)10-2-3-13(20)14(21)7-10)5-9-1-4-15-12(6-9)19-17(23)24-15/h1-7,20-21H,(H,19,23)/b11-5+ |
CAS Number | 638213-98-6 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | >98% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |